sellWeak
Shao-Lee Lin sold $79k of SLRN
Chief Executive Officer at ACELYRIN, Inc.. 10,691 shares at an average of $7.41, traded Jan 2, 2024, filed Jan 4, 2024.
Warning score
34Value
$79k
10,691 shares
Holdings after
1,603,036
-1% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- +9Trade size$79k at market
- 0Share of holdings soldSold 0.7% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001962918-24-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 2, 2024 | SOpen-market sale Common Stock | -10,691 | $7.41 | $79k | 1,603,036 | Jan 4, 2024 |
Related signals
Other insiders at ACELYRIN, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | ACELYRIN, Inc. | Shephard Mpofu Chief Medical Officer | $8,811 3,211 shares | -3% | |
| 30Weak | ACELYRIN, Inc. | Amar Murugan Chief Legal Officer | $11k 3,913 shares | -3% | |
| 47Moderate | ACELYRIN, Inc. | Mina Kim Chief Executive Officer | $49k 17,986 shares | -3% | |
| 33Weak | SLRNsell ACELYRIN, Inc. | Shao-Lee Lin Chief Executive Officer | $66k 9,961 shares | -1% | |
| 35Weak | SLRNsell ACELYRIN, Inc. | Shao-Lee Lin Chief Executive Officer | $119k 15,701 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.